Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #21.4     COVID 19. Update #3     The past week news flow has been particularly rich with nevertheless three topics on the forefront:  vaccine supplies, rapid emergence of new SARS-CoV-2 variants, debate on the use of antibodies to treat […]

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #21.3     COVID 19 Treatments Update #2     In spite of the numerous announcements made at the JP Morgan Healthcare Conference this week, COVID-19 treatments remain the main topic of the Biopharmaceutical companies’ agenda At the dawn of the […]

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com       SPECIAL REPORT #21.2     Novel Drug Approvals for 2020     According to a report issued by the U.S. FDA’s Center for Drug Evaluation and Research (CDER) the agency has approved  53 new drugs and biological products in 2020. If one […]

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #21.1   We wish all our readers and friends a Happy and Healthy Year 2021.   COVID-19 Vaccines: Update 1     The past year has been unusual through many aspects but the emergence, in January 2020, of the SARS-CoV-2 virus […]